These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1433752)

  • 41. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duration of serum anticapsular antibody after a two-dose regimen of a Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine and anamnestic response after a third dose.
    Sood SK; Ballanco GA; Daum RS
    J Pediatr; 1991 Oct; 119(4):652-4. PubMed ID: 1919901
    [No Abstract]   [Full Text] [Related]  

  • 43. Additional dose urged for some receiving Haemophilus influenzae vaccine in early '90s.
    Marwick C
    JAMA; 1992 Dec; 268(23):3287. PubMed ID: 1453513
    [No Abstract]   [Full Text] [Related]  

  • 44. [Conjugated vaccines against Haemophilus influenzae type b].
    Rümke HC; Poolman JT
    Ned Tijdschr Geneeskd; 1991 Jan; 135(1):4-7. PubMed ID: 2012643
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine.
    Munoz A; Salvador A; Brodsky NL; Arbeter AM; Porat R
    Pediatrics; 1995 Aug; 96(2 Pt 1):216-9. PubMed ID: 7630672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine.
    Mulholland EK; Todd J; Rowe M; Campbell H; Byass P; Vella PP; Ahonkhai VI; Greenwood BM
    Ann Trop Paediatr; 1993; 13(2):153-8. PubMed ID: 7687111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization of leukemic children with Haemophilus conjugate vaccine.
    Lange B; Jakacki R; Nasab AH; Luery N; McVerry PH
    Pediatr Infect Dis J; 1989 Dec; 8(12):883-4. PubMed ID: 2626288
    [No Abstract]   [Full Text] [Related]  

  • 50. H influenzae vaccines gain favor.
    Marwick C
    JAMA; 1990 Sep; 264(11):1375. PubMed ID: 2391729
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
    Adderson EE; Chisholm N; Halperin SA
    Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contemporary trends in conjugate vaccine development.
    Cruse JM; Lewis RE
    Contrib Microbiol Immunol; 1989; 10():1-10. PubMed ID: 2510970
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Daum RS; Siber GR; Ballanco GA; Sood SK
    J Infect Dis; 1991 Dec; 164(6):1154-9. PubMed ID: 1955715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hemophilus influenzae infection and their prevention by vaccination].
    Scholz H; Noack R
    Kinderarztl Prax; 1993 Aug; 61(6):189-91. PubMed ID: 8411843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
    Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
    [No Abstract]   [Full Text] [Related]  

  • 56. Haemophilus influenzae type b prevention.
    N Y State J Med; 1989 Jul; 89(7):430-1. PubMed ID: 2788257
    [No Abstract]   [Full Text] [Related]  

  • 57. H. influenzae vaccine for infants.
    Med Lett Drugs Ther; 1991 Jan; 33(836):5-7. PubMed ID: 1986208
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine.
    Walter EB; Simmons SS; Clements DA
    J Infect Dis; 1994 Oct; 170(4):1050-1. PubMed ID: 7930710
    [No Abstract]   [Full Text] [Related]  

  • 59. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
    Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
    Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 1990s: a decade of new vaccines.
    Murphy TV
    Pediatr Infect Dis J; 1991 Feb; 10(2):89-91. PubMed ID: 2062619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.